Original Investigation

Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments

JAMA Network Open 10.1001/jamanetworkopen.2025.38729

October 22, 2025 at 11:00 AM EDT

Read the full article

Did influenza antiviral prescribing for influenza-positive children at higher risk of severe illness in the emergency department (ED) change from 2016 to 2023, and what factors are associated with prescribing?In this cross-sectional study of 2514 children at higher risk for severe influenza in the ED, 32.2% received antiviral prescriptions before the COVID-19 pandemic (2016-2020) vs 15.6% in the late pandemic period (2021-2023). Antivirals were more commonly prescribed to children presenting within 2 days of symptom onset and among those who received clinical influenza testing.These findings demonstrate a decline in prescribing despite unchanged treatment guidelines, highlighting opportunities to improve practice.

Corresponding Author: Tess Stopczynski, MS, Department of Biostatistics, Vanderbilt University Medical Center, 2525 West End Ave, Ste 1020, Nashville, TN 37203 (tess.stopczynski@vumc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.38729?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102225

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks